190P Observational Cohort Study of 1st Line Bevacizumab Combined With Chemotherapy in Metastatic Colorectal Cancer (HGCSG0802): Sub-Group Analysis by the Glasgow Prognostic Score (GPS)

Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdw581.023